Cargando…
Smad3 Inactivation and MiR-29b Upregulation Mediate the Effect of Carvedilol on Attenuating the Acute Myocardium Infarction-Induced Myocardial Fibrosis in Rat
Carvedilol, a nonselective β-adrenoreceptor antagonist, protects against myocardial injury induced by acute myocardium infarction (AMI). The mechanisms underlying the anti-fibrotic effects of carvedilol are unknown. Recent studies have revealed the critical role of microRNAs (miRNAs) in a variety of...
Autores principales: | Zhu, Jie-Ning, Chen, Ren, Fu, Yong-Heng, Lin, Qiu-Xiong, Huang, Shuai, Guo, Lin-Lin, Zhang, Meng-Zhen, Deng, Chun-Yu, Zou, Xiao, Zhong, Shi-Long, Yang, Min, Zhuang, Jian, Yu, Xi-Yong, Shan, Zhi-Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3783413/ https://www.ncbi.nlm.nih.gov/pubmed/24086569 http://dx.doi.org/10.1371/journal.pone.0075557 |
Ejemplares similares
-
Carvedilol Attenuates the Progression of Hepatic Fibrosis Induced by Bile Duct Ligation
por: Tian, Xiaopeng, et al.
Publicado: (2017) -
TNAP inhibition attenuates cardiac fibrosis induced by myocardial infarction through deactivating TGF-β1/Smads and activating P53 signaling pathways
por: Gao, Lei, et al.
Publicado: (2020) -
(Pro)renin Receptor Knockdown Attenuates Liver Fibrosis Through Inactivation of ERK/TGF-β1/SMAD3 Pathway
por: Hsieh, Yun-Cheng, et al.
Publicado: (2021) -
Carvedilol attenuates carbon tetrachloride-induced liver fibrosis and hepatic sinusoidal capillarization in mice
por: Wu, Ying, et al.
Publicado: (2019) -
Reappraisal of Antihypertensive Medicine Doxazosin and Carvedilol as a Potential Therapeutic for Hepatic Fibrosis
por: Paik, Yong-Han
Publicado: (2016)